Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'blind' OR with Authors including 'blind' OR with Abstract including 'blind' OR with Keywords including 'blind'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Forrer GR, Goldner RD Experimental physiological studies with lysergic acid diethylamide (LS... Arch. Neurol. 1951
AlemÓ G Allucinazioni da acido lisergico in cieco senza bulbi oculari Riv. Neur. 1952
Greiner T, Burch NR, Edel... Psychopathology and psychophysiology of minimal LSD-25 dosage. A prel... Arch. Neurol. & Psyc... 1958
Bishop PO, Field G, Henne... Action of d-lysergic acid diethylamide on lateral geniculate synapses. J.Neurophysiol. 1958
Isbell H Effects of various drugs on the LSD reaction Psychopharmacology F... 1959
Cutting W, Baslow M, Read... The use of fish in the evaluation of drugs affecting the central nervo... J.Clin.& Exper.Psych... 1959
Isbell H, Miner EJ, Logan... Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) ... Psychopharmacologia 1959
Demaar EWJ, Williams HL, ... Effects in man of single and combined oral doses of reserpine, ipronia... Clin.Pharmacol.Thera... 1960
Klee GD, Bertino J, Calla... Clinical studies with LSD-25 and two substances related to serotonin J.Ment.Sci. 1960
Lebovits BZ, Visotsky HM,... LSD and JB-318: A comparison of two hallucinogens. I. An explorator... A.M.A. Arch. gen. Ps... 1960
Krill AE, Wieland AM, Ost... The effect of two hallucinogenic agents on human retinal function AMA Arch. Ophth. 1960
Silva F, Heath RG, Raffer... Comparative effects of the administration of Taraxein, d-LSD, Mescalin... Comprehensive Psychi... 1960
Bertino JR, Klee GD, Coll... Clinical studies with dibenzyline and lysergic acid diethylamide J.Clin.Exper.Psychop... 1960
Krus DM, Wapner S, Bergen... The influence of progesterone on behavioral changes induced by lysergi... Psychopharmacologia 1961
Krill AE, Alpert HJ, Ostf... Effects of a hallucinogenic agent in totally blind subjects Arch. Ophthal. 1963
Pahnke W Drugs and Mysticism: An Analysis of the Relationship between Psychedel... Thesis Harvard Unive... 1963
Savage C, Savage E, Fadim... LSD: Therapeutic Effects of the Psychedelic Experience Psychol. Reports 1964
Kast EC, Collins VJ Lysergic acid diethylamide as an analgesic agent Anesth. Analg. Curr.... 1964
Park LC, Covi L Nonblind Placebo Trial: An Exploration of Neurotic Patients' Responses... Arch Gen Psychiatry 1965
Haertzen CA Changes in correlation between responses to items of the Addiction Res... J of Psychopharmacol... 1966
Snyder SH, Faillace LA, W... DOM STP, a new hallucinogenic drug, and DOET: effects in normal subjec... Am J Psychiatry 1968
Tjio, JH, Pahnke WN, Kurl... LSD and chromosomes, A controlled experiment J. Amer. Med. Ass. 1969
Dittrich A Alteration of behavioural changes induced by 3,4,5-trimethoxyphenyleth... Psychopharmacologia 1971
Schatz H, Mendelblatt F Solar retinopathy from sun-gazing under the influence of LSD Br J Ophthalmol 1973
Soskin RA The Use of LSD in Time-Limited Psychotherapy J Nerv Ment Dis 1973
Soskin RA, Grof S, Richar... Low Doses of Dipropyltryptamine in Psychotherapy Arch Gen Psychiat 1973
Fernandez J, Browne IW, C... LSD...an in vivo retrospective chromosome study. Annals of Human Gene... 1973
Campbell H, Cline W, Evan... Comparison of the effects of dexamphetamine and 1-benzylpiperazine in ... Eur J Clin Pharmacol 1973
Bye C, Munro-Faure AD, Pe... A comparison of the effects of 1-benzylpiperazine and dexamphetamine o... Eur J Clin Pharmacol 1973
Stone TW The changes in basal corticosterone secretion in rats blinded at birth Experientia 1974
Van Putten T, Hollingswor... CA Diphenylhydantoin in the treatment of LSD flashbacks: a case study Newsletter for Resea... 1974
Griffith JD, Nutt JG, Jas... A comparison of fenfluramine and amphetamine in man Clin Pharmacol Ther 1975
Grant I, Mohns L, Miller ... A Neuropsychological Study of Polydrug Users Arch Gen Psychiatry 1976
Jacobs BL, Trulson ME, St... An Animal Behavior Model for Studying the Actions of LSD and Related H... Science 1976
Siegel RK, Brewster JM, J... The Effects of Hallucinogens On Blind Monkeys Intern.Pharmacopsych... 1976
Smith JM, Misiak H Critical Flicker Frequency (CFF) and Psychotropic Drugs in Normal Huma... Psychopharmacology 1976
Rhead JC, Soskin RA, Ture... Psychedelic Drug (DPT)-Assisted Psychotherapy with Alcoholics: A Contr... J of Psychedelic Dru... 1977
Schlemmer RF, Tyler CB, N... The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social A... Federation Proceedin... 1978
Natale M, Kowitt M, Dahlb... Effect of Psychotomimetics (LSD and Dextroamphetamine) on the Use of F... Journal of Consultin... 1978
Schlemmer RF, Heinze WJ, ... Evidence For Serotonin Mediation Of LSD-induced Abnormal Behavior In M... Federation Proc. 1979
Natale M, Dahlberg CC, Ja... The Effect of Psychotomimetics On Therapist-patient Matching Of Speech... J. Communicat. Disor... 1979
Natale M, Dahlberg CC, Ja... The Effects Of LSD-25 And Dextroamphetamine On The Use Of Defensive La... J. clin. Psychol. 1979
Levine JD, Gordon NC, Bor... Role of pain in placebo analgesia Proc Natl Acad Sci U... 1979
McLellan, AT, Woody GE, O... Psychiatric Illness in Drug Abusers New Engl. J. Med. 1980
Jaffe JH, Kanzler M, Gree... Abuse potential of loperamide Clin Pharmacol Ther 1980
Heinze WJ, Schlemner RF, ... The Comparative Effects of d-LSD & d-Amphetamine on Stereotyped Behavi... Federation Proceedin... 1981
Schlemmer RF, Davis JM LSD-induced Behavioral Changes In Selected Members Of A Primate Social... Behavioral Pharmacol... 1981
Marini JL, Jacobs BL, She... Activity of a Non-Hallucinogenic Ergoline Derivative, Lisuride, in an ... Psychopharmacology 1981
Beckwith BE, Couk DI, Til... Vasopressin analog influences the performance of males on a reaction t... Peptides 1983
Nebes RD, Reynolds CF, Ho... The effect of vasopressin on memory in the healthy elderly Psychiatry Res 1984
Guard O, Marchal G, Graul... Effects of vasopressin and desmopressin on memoryA double-blind study ... Neuropsychobiology 1986
Mayagoitia L, DÝaz JL, Co... Psychopharmacologic analysis of an alleged oneirogenic plant: Calea za... J Ethnopharmacol 1986
Beeghly JH, Kuperman S, P... Fenfluramine treatment of autism: relationship of treatment response t... J Autism Dev Disord 1987
Loke WH Effects of caffeine on mood and memory Physiol Behav 1988
Colombo F, Sega R, Mailla... Beta-blockade antagonism of tyramine-induced rise in blood pressure Eur J Clin Pharmacol 1988
Dons RF, House JF, Hood D... Assessment of desmopressin-enhanced cognitive function in a neurosurgi... Mil Med 1989
Bailey PL, Streisand JB, ... Differences in magnitude and duration of opioid-induced respiratory de... Anesth Analg 1990
Lapierre O, Montplaisir J... The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of ... Sleep 1990
Greer GR,Tolbert R The Therapeutic Use of MDMA Ecstasy: The clinica... 1990
Perez-Reyes M, Burstein S... Antagonism of marihuana effects by indomethacin in humans Life Sci 1991
Warnecke G [Psychosomatic dysfunctions in the female climactericClinical effectiv... Fortschr Med 1991
Zeki S Cerebral akinetopsia (visual motion blindness)A review Brain 1991
Kinzler E, Kr├Âmer J, Leh... [Effect of a special kava extract in patients with anxiety-, tension-,... Arzneimittelforschun... 1991
Yensen R, Dryer D Thirty Years of Psychedelic Research: The Spring Grove Experiment and ... Orenda Institute 1992
Gouzoulis E, Steiger A, E... Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... Biol Psychiatry 1992
Beckers G, H÷mberg V Cerebral visual motion blindness: transitory akinetopsia induced by tr... Proc Biol Sci 1992
Huestis MA, Henningfield ... Blood cannabinoidsIAbsorption of THC and formation of 11-OH-THC and TH... J Anal Toxicol 1992
Munte TF, Heinze HJ, Matz... Effects of oxazepam and an extract of kava roots (Piper methysticum) o... Neuropsychobiology 1993
Herberg KW [Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on... Blutalkohol 1993
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Gouzoulis E, von Bardeleb... Neuroendocrine and cardiovascular effects of MDE in healthy volunteers Neuropsychopharmacol... 1993
Strassman RJ, Qualls CR, ... Dose-response study of N,N-dimethyltryptamine in humans. II. Subjectiv... Arch Gen Psychiatry 1994
Strassman RJ, Qualls CR Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... Arch Gen Psychiatry 1994
Rush CR, Sullivan JT, Gri... Intravenous caffeine in stimulant drug abusers: subjective reports and... J Pharmacol Exp Ther 1995
Storrow AB, Magoon MR, No... The dextromethorphan defense: dextromethorphan and the opioid screen Acad Emerg Med 1995
Strassman RJ, Qualls CR, ... Differential tolerance to biological and subjective effects of four cl... Biol Psychiatry 1996
Grob CS, Poland RE, Chang... Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans:... Behav Brain Res 1996
Van Toi V, Abraham H, Bu... Post-LSD Hallucinosis Is Associated With Decrease In Flicker-Fusion Se... Investigative Ophtha... 1996
Halpern JH The Use of Hallucinogens in the Treatment of Addiction Addiction Research 1996
Benjamin J, Greenberg BD,... Daily administration of m-chlorophenylpiperazine to healthy human volu... Psychopharmacology B... 1996
Volz HP, Kieser M Kava-kava extract WS 1490 versus placebo in anxiety disorders--a rando... Pharmacopsychiatry 1997
Nikolajsen L, Hansen PO, ... Oral ketamine therapy in the treatment of postamputation stump pain Acta Anaesthesiol Sc... 1997
Schuh KJ, Griffiths RR Caffeine reinforcement: the role of withdrawal Psychopharmacology (... 1997
Buydens-Branchey L, Branc... Hormonal, psychological, and alcohol craving changes after m-chlorophe... Alcohol Clin Exp Res 1997
Nelson KA, Park KM, Robin... High-dose oral dextromethorphan versus placebo in painful diabetic neu... Neurology 1997
Vollenweider FX, Gamma A,... Psychological and cardiovascular effects and short-term sequelae of MD... Neuropsychopharmacol... 1998
Lane JD, Kasian SJ, Owens... Binaural auditory beats affect vigilance performance and mood Physiol Behav 1998
Bowdle TA, Radant AD, Cow... Psychedelic effects of ketamine in healthy volunteers: relationship to... Anesthesiology 1998
Gouzoulis-Mayfrank E, Hee... Effects of the hallucinogen psilocybin on habituation and prepulse inh... Behav Pharmacol 1998
Benowitz NL, Zevin S, Jac... Suppression of nicotine intake during ad libitum cigarette smoking by ... J Pharmacol Exp Ther 1998
Mas M, Farre M, de la Tor... Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... J Pharmacol Exp Ther 1999
Vollenweider FX, Gamma A,... Is a single dose of MDMA harmless? Neuropsychopharmacol... 1999
Vollenweider FX, Remensbe... Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensor... Psychopharmacology (... 1999
McCann UD, Eligulashvili ... Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... Psychopharmacology (... 1999
Gouzoulis-Mayfrank E, The... Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... Psychopharmacology (... 1999
Pacifici R, Zuccaro P, Fa... Immunomodulating properties of MDMA alone and in combination with alco... Life Sci 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Schreckenberger M, Gouzou... "Ecstasy"-induced changes of cerebral glucose metabolism and their cor... Eur J Nucl Med 2000

Page 1 of 3   /   241 Entries Returned
Pages:     
 1 
2 3 next